Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Drug-Coated Stents Reduce Repeat Artery Procedures


Related Encyclopedia
 border=
Alzheimer's Disease
Aneurysms
Angina Pectoris
Angiogram
More...

Related Healthscout Videos
 border=
Nutrition and Cancer
Nutrition and Osteoporosis
Importance of Good Nutrition
Controlling Incontinence
More...

Related Animations
 border=
Alzheimer's Disease Video Animation
Angioplasty
Coronary Bypass Surgery
Erectile Dysfunction
More...

Related Drug Information
 border=
Accupril
Actonel
Altace
Avapro
More...

Related News Articles
 border=
Study Recruiting From Alzheimer's-Prone Families
Transfusing Anemic Cancer Patients Boosts Clot Risk
Beware of Toxic Toys This Holiday Season
At Home Heart Watch
More...


Page:  << Prev | 1 | 2 | 3 | Next >>

But the bottom line is that drug-coated stents did decrease the need for new procedures when an artery became blocked again, the study found. Drug-coated stents might increase the incidence of such blockages, "but when you compare the increased risk of late thrombosis [clotting] associated with drug-eluting stents, that risk is more than counterbalanced by reducing the adverse events associated with revascularization [artery-reopening procedures]," Malenka said.

The study was funded in part by the U.S. National Institute on Aging and is published in the June 25 issue of the Journal of the American Medical Association.

While drug-coated stents are now used in perhaps 70 percent of cases, the bare-metal kind has its uses, Malenka said. "We understand that patients who get drug-eluting stents have to be on two antiplatelet [clot-preventing] drugs for at least a year," he said. "Not everyone can be able to afford them or be compliant with their use."

Text Continues Below



Dr. Kirk Garratt, clinical director of interventional cardiovascular research at Lenox Hill Hospital's Heart and Vascular Institute in New York City, said the new study helps to establish the appropriate use of drug-coated stents.

"We went through a difficult period when it appeared there might be real problems with drug-eluting stents involving clot formation, leading to deaths and heart attacks," Garratt said. "We found that, in fact, there does not seem to be an important signal of risk with drug-eluting stents around the world."

The Dartmouth report is the latest in "half a dozen studies, all of which indicate the use of drug-eluting stents is perfectly safe and does yield an important reduction in the need for further procedures," Garratt said.

The study was done before a second coated stent, Boston Scientific Corp.'s paclitaxel-coated Taxus, was marketed. The U.S. Food and Drug Administration has just approved a third model, Medtronic's Endeavor, coated with zotarolimus, and other products are in the testing pipeline.

Page:  << Prev | 1 | 2 | 3 | Next >>

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 6/25/2008

Related Links
 border=
From Healthscout's partner site on heart disease, MyHeartCentral.com
Learn about heart disease symptoms.
Get more information on heart disease treatment for your health!
What can you do to prevent heart disease? Prevention details here.





SOURCES: David J. Malenka, M.D., cardiologist, Dartmouth Medical School, Lebanon N.H.; Kirk Garratt, M.D., clinical director of interventional cardiovascular research, Lenox Hill Hospital Heart and Vascular Institute, New York City; June 25, 2008, Journal of the American Medical Association


We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001-2008. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map